LYSOWAY THERAPEUTICs

Lysoway Therapeutics has developed unique technological approaches to screen and develop potent modulators of lysosomal ion channels.

[Top] This infographic shows the restoration of lysosomal function, which can then better regulate critical downstream processes to provide therapeutic benefit to patients.

[Bottom] This infographic shows the results of the pharmacological activation of TRPML1 in Alzheimer’s and Parkinson’s disease mouse models.

Back to Information Design